The following is a summary of “Biomarkers of oxidation, inflammation and intestinal permeability in persons with diabetes ...

Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the ...

ICU Medical, Inc. is voluntarily recalling one lot each of POTASSIUM CHLORIDE Inj. bags with overwrap labels 10 mEq, packaged ...

Consultant Dr Kulkarni carried out a range of tests, which, over the following months, revealed Harmony had tracheomalacia ...

A randomized, controlled trial was conducted to evaluate the effects of intradialytic parenteral nutrition (IDPN) using ENEFLUID® in malnourished hemodialysis patients. While no changes were ...

The global peptide therapeutics market size has been estimated at USD 52.59 billion in 2025 and is expected to reach around ...

What does the Desmoid Tumor Working Group recommend for patients with potential desmoid tumors? 1. Nam Quoc Bui, MD: The ...

The HYPERION study will be stopped early due to positive efficacy data from across the sotatercept clinical program.

The findings from the PROSPERO study reveal that multiple hospitalizations, long-term disease duration, prior surgeries, and factors like corticosteroid use and total parenteral nutrition ...

San Francisco, California Wednesday, February 5, 2025, 16:00 Hrs [IST] ...